Standardized labeling may be key to CBD legality
(This is an abridged version of a story that appears in the February issue of Marijuana Business Magazine.) The CBD industry is in desperate need of an idiot-proof way to distinguish legal CBD from illegal varieties derived from marijuana. Could the solution be found in Utah? The conservative western state... Read more
Marijuana companies look to build big business in hemp
Two large cannabis companies said Monday they are investing in developing their own lines of hemp-derived products by opening subsidiary companies. Chicago-based Cresco Labs, a vertically integrated, multistate cannabis operator, is opening Well Beings to offer a full line of hemp-derived products eligible for national distribution, as well as CBD... Read more
Show Me The Money! Banking Hearing Held In Congress Last Week
by Michelle Rutter, NCIA Government Relations Manager A week ago today, the House Financial Services Committee made history. On Wednesday, the Subcommittee on Consumer Protection and Financial Institutions held its first ever hearing on marijuana and financial services, entitled: Challenges and Solutions: Access to Banking Services for Cannabis-Related Businesses.... Read more
Five Reasons Why NCIA’s Industry Socials Were A Huge Success
At the end of 2018, NCIA’s events team looked ahead at how to make our line-up of 2019 events even better and respond to an increasingly popular demand for more networking opportunities. As a team we dreamed up how to make a B2B networking series that was not only... Read more
Arizona hemp farmers get green light to plant in June
Hemp farmers in Arizona can now begin planting two months earlier than originally planned, thanks to a bill signed into law by Gov. Doug Ducey. State Sen. Sonny Borrelli of Lake Havasu City sponsored the bill, which could permit farmers to plant as early as June rather than waiting for... Read more
GW Pharma denies supply issues with cannabis-based drug Epidiolex after stock falls
GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply issues related to the cannabis-derived drug after a tweet from a patient’s father complained he could not source the medicine. GW’s stock was down more than 3% on Wednesday on the... Read more
Tilray makes CBD move with Manitoba Harvest acquisition
Cannabis giant Tilray is expanding into the natural foods category with the acquisition of hemp foods company Manitoba Harvest for 419 million Canadian dollars ($319 million) in cash and stock in an effort to capitalize on cannabidiol-infused products in North America. The acquisition will accelerate British Columbia-based Tilray’s expansion... Read more
What is CBD skin care worth? Industry executives talk market opportunities as retailers buy in
As companies prepare for legal changes to the hemp industry after the plant’s federal reclassification, a sleeping giant in the CBD sector is beginning to step into its full financial potential: skin-care products. The $18 billion U.S. skin-care industry is seeing a flood of CBD entrants, including large retailers such... Read more
Last week, as NCIA wrapped up another successful Seed to Sale Show, we were vigilantly preparing for a historic hearing about the issue of cannabis banking and the SAFE Banking Act. This is an incredible milestone for our industry. If this bill passes, it would allow marijuana-related businesses in... Read more
Congress to FDA: We need CBD answers by Friday
(This article has been updated to include a response from the FDA.) Saying that states need “immediate leadership” on CBD in foods, drugs and cosmetics, 12 members of Congress have asked the head of the U.S. Food and Drug Administration (FDA) to release updated guidance by Friday. The letter,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )